ストックスクリーナーアプリを入手
0.51
2.70%
0.0134
アフターアワーズ：
.47
-0.04
-7.84%
前日終値:
$0.4966
開ける：
$0.4937
24時間の取引高:
264.73K
Relative Volume:
0.03
時価総額：
$8.99M
収益：
$9.37M
当期純損益:
$-8.45M
株価収益率:
-0.6296
EPS:
-0.81
ネットキャッシュフロー:
$-7.27M
1週間 パフォーマンス:
+2.25%
1か月 パフォーマンス:
+84.52%
6か月 パフォーマンス:
-64.83%
1年 パフォーマンス:
-83.00%
1日の値動き範囲:
$0.4602
$0.52
1週間の範囲:
$0.4602
$0.5814
52週間の値動き範囲:
$0.2404
$3.10
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
名前
Bioaffinity Technologies Inc
セクター
電話
210-698-5334
住所
3300 NACOGDOCHES ROAD, SAN ANTONIO
BIAF を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
0.51 | 8.99M | 9.37M | -8.45M | -7.27M | -0.81 |
|
TMO
Thermo Fisher Scientific Inc
|
434.73 | 166.47B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
192.07 | 135.88B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
421.59 | 32.74B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
102.81 | 29.40B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
143.61 | 26.30B | 15.41B | 1.37B | 2.11B | 7.50 |
Bioaffinity Technologies Inc (BIAF) 最新ニュース
bioAffinity Technologies streamlines lung cancer detection test By Investing.com - Investing.com Canada
bioAffinity Technologies Increases Efficiency of CyPath® Lung Test by Boosting Data Acquisition Throughput by 50% and Reducing Unit Cost - BioSpace
bioAffinity Technologies streamlines lung cancer detection test - Investing.com
Bioaffinity Technologies Increases Efficiency Of Cypath Lung Test - marketscreener.com
ASP Isotopes and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Corsicana Daily Sun
bioAffinity Technologies Board Member Announces Departure - TipRanks
CyPath Lung Helped Detect Breast Cancer Recurrence - Medical Product Outsourcing
Bioaffinity Technologies Files For Resale Of Up To 3.0 Million Shares Of Common Stock By Selling StockholdersSEC Filing - MarketScreener
bioAffinity Technologies Reports Record Revenue for 2024 - TipRanks
BIAF Stock Surges Post Improved Earnings and Record 2024 Revenues - Yahoo Finance
Earnings roundup: Usio back in the black; losses widen at bioAffinity, Wytec - San Antonio Express-News
bioAffinity Technologies and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Joplin Globe
bioAffinity Technologies Stock Price, Quotes and Forecasts | NASDAQ:BIAF - Benzinga
Best Biotech Stocks To Follow Today – April 1st - Defense World
Biotech stock bioAffinity Technologies, Inc. (NASDAQ: BIAF) Makes NASDAQ Top Percentage Gainer on News - Investorideas.com
Take off with BioAffinity Technologies Inc (BIAF): Get ready for trading - Sete News
bioAffinity Technologies Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
bioAffinity Technologies (NASDAQ:BIAF) Given Hold Rating at Maxim Group - Defense World
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Lung cancer spit test fast-tracks a San Antonio biotech company for growth - MSN
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Nasdaq Surges 1%; US Construction Spending Rises In February - Benzinga
Dow Dips Over 400 Points; ISM Manufacturing PMI Falls In March - Benzinga
What's Going On With BioAffinity Shares Tuesday? - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
bioAffinity Technologies stock hits 52-week low at $0.25 By Investing.com - Investing.com South Africa
bioAffinity Technologies, Inc. SEC 10-K Report - TradingView
bioAffinity Technologies earnings missed by $0.05, revenue fell short of estimates - Investing.com Canada
bioAffinity posts 270% revenue rise with Medicare coverage - Investing.com
bioAffinity Technologies stock hits 52-week low at $0.25 - Investing.com
bioAffinity posts 270% revenue rise with Medicare coverage By Investing.com - Investing.com India
Record-Breaking 270% Revenue Surge: bioAffinity's Growth Story Takes Unexpected Turn - Stock Titan
bioAffinity Technologies Reports Record $9.4 Million Revenue for 2024 - The Joplin Globe
Case Study: bioAffinity Technologies’ CyPath® Lung Detects Second Primary Lung Cancer in Patient With History of Lung Cancer - BioSpace
BIOAFFINITY TECHNOLOGIES Earnings Preview: Recent $BIAF Insider Trading, Hedge Fund Activity, and More - Nasdaq
Lung Detects Second Primary Lung Cancer in Patient With History of Lung Cancer - Business Wire
bioAffinity Technologies (NASDAQ:BIAFW) Shares Down 24.3% – Here’s What Happened - Defense World
bioAffinity stock hits 52-week low at $0.26 amid market challenges - Investing.com Australia
BioAffinity Technologies Inc (BIAF): An Important Analyst Insights - Stocks Register
Case Study: bioAffinity Technologies’ Positive CyPath® Lung Result Leads to Detecting Breast Cancer Recurrence - BioSpace
bioAffinity stock hits 52-week low at $0.26 amid market challenges By Investing.com - Investing.com South Africa
bioAffinity Technologies Cutting Jobs to Save $4 Million in Operating Costs - MPO-mag
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
bioAffinity Technologies Announces Pricing of Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million - Business Wire
Physicians’ Case Studies Offer Insight into Use and Benefit of CyPath® Lung in Avoiding Unnecessary Invasive Procedures and Detecting Lung Cancer - Joplin Globe
Bioaffinity Technologies Inc (BIAF) 財務データ
収益
当期純利益
現金流量
EPS
6.78%
大文字化:
|
ボリューム (24 時間):